NEWS12 January 2010
All MRS websites use cookies to help us improve our services. Any data collected is anonymised. If you continue using this site without accepting cookies you may experience some performance issues. Read about our cookies here.
All MRS websites use cookies to help us improve our services. Any data collected is anonymised. If you continue using this site without accepting cookies you may experience some performance issues. Read about our cookies here.
Insight & Strategy
Columnists
Impact magazine is a quarterly publication for MRS members. You can access Impact content on this website.
US— Healthcare data and research firm SK&A has been sold to Cegedim Dendrite, a CRM services business focused on the life sciences industry.
SK&A holds contact and profiling information on more than two million healthcare practitioners, which Cegedim plans to use to bolster its OneKey database services in the US.
Dave Escalante, SK&A’s president and CEO, will continue to lead the business in his new role of vice president of data and information solutions.
Cegedim Dendrite is part of the Cegedim Group, which has headquarters in France. Previous acquisitions include patient data firm Hospital Marketing Services and pharma intelligence firm Nomi.
Newsletter
Sign up for the latest news and opinion.
You will be asked to create an account which also gives you free access to premium Impact content.
It is important to recognise and embrace the benefits of working in the market research industry, writes Louise McL… https://t.co/r7qSMTIVKk
Course5 Intelligence secures $28m investment https://t.co/tPodAbFUx1 #mrx #marketresearch
Aspect to launch Manchester viewing facility https://t.co/9ZQBkbPRMN #mrx #marketresearch
The world's leading job site for research and insight
Spalding Goobey Associates
Clientside Senior Research Executive, Quant – 18 month contract
£32–38,000 + benefits
Hasson Associates
Client Service Engagement Manager
£40000–52000
Differentology
Market Research Creative Internship – Summer Placement
You will be paid £10.42 per hour
Ishwar
13 years ago
I believe that Cegedim could be a major contender as a data vendor, but I feel that general information like prescriber information should be readily available to pharma companies via a congregated effort by them which would bring doen their data acquisition costs significantly.
RT @researchlive: MRS and MTab partner on training and certification https://t.co/r3ehEDDGRs #mrx #marketresearch
The post-demographic consumerism trend means segments such age are often outdated, from @trendwatching #TrendSemLON
1 Comment
Ishwar
13 years ago
I believe that Cegedim could be a major contender as a data vendor, but I feel that general information like prescriber information should be readily available to pharma companies via a congregated effort by them which would bring doen their data acquisition costs significantly.
Like Reply Report